Vyriad
Mr. Hannon is an experienced senior executive with extensive general and financial management experience in business operations, acquisition, divestiture and capital structuring. His industry experience includes biotechnology, biomedical, printing, manufacturing, distribution and alternative energies. Mr. Hannon received a bachelor’s degree in Management and Accounting from the University of St. Thomas and master’s degree in Management from the Stanford Sloan Graduate School of Business. Mr. Hannon is also the Private Equity Manager for Quinstar Investment Partners.
This person is not in any offices
Vyriad
Vyriad is developing the next generation of targeted cancer therapies using engineered viruses that selectively attack cancer cells and ignite robust immune responses to prevent cancer recurrence.